Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Teng Cheong Ha"'
Autor:
Ann-Christin Franke, Romain Hardet, Lisa Prager, Martin Bentler, Mélanie Demeules, Philipp John-Neek, Nico Martin Jäschke, Teng Cheong Ha, Ulrich Thorsten Hacker, Sahil Adriouch, Hildegard Büning
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 29, Iss , Pp 238-253 (2023)
Immunotherapy has significantly improved treatment outcomes in various cancer entities. To enhance immunogenicity and efficacy, and to further broaden its applicability, co-administration of anti-tumor vaccines is considered as a promising strategy.
Externí odkaz:
https://doaj.org/article/60289b2c07f7465484685690b5e11a75
Autor:
Maike Stahlhut, Teng Cheong Ha, Ekaterina Takmakova, Michael A. Morgan, Adrian Schwarzer, Dirk Schaudien, Matthias Eder, Axel Schambach, Olga S. Kustikova
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-18 (2021)
Abstract Regulation of haematopoietic stem cell fate through conditional gene expression could improve understanding of healthy haematopoietic and leukaemia initiating cell (LIC) biology. We established conditionally immortalised myeloid progenitor c
Externí odkaz:
https://doaj.org/article/abfa46b0214b432b946d8f86d4a0f23f
Autor:
Lucas Lange, Dirk Hoffmann, Adrian Schwarzer, Teng-Cheong Ha, Friederike Philipp, Daniela Lenz, Michael Morgan, Axel Schambach
Publikováno v:
Stem Cell Reports, Vol 14, Iss 1, Pp 122-137 (2020)
Summary: Induced pluripotent stem cells (iPSCs) offer a promising platform to model early embryonic developmental processes, to create disease models that can be evaluated by drug screens as well as proof-of-concept experiments for regenerative medic
Externí odkaz:
https://doaj.org/article/6d42135a779e40799f8fcbee24bcd545
Autor:
Anton Selich, Teng-Cheong Ha, Michael Morgan, Christine S. Falk, Constantin von Kaisenberg, Axel Schambach, Michael Rothe
Publikováno v:
Stem Cell Reports, Vol 13, Iss 2, Pp 262-273 (2019)
Summary: Mesenchymal stromal cells (MSCs) are used in many clinical applications. However, ex vivo expansion is required to reach clinically relevant cell numbers, which might lead to selection of clones with different characteristics. To follow clon
Externí odkaz:
https://doaj.org/article/5f9d4f8152b1471e9a64d3ff3eb7aa91
Publikováno v:
Human Gene Therapy. 32:1280-1294
Hematopoietic stem cells (HSC) represent a rare cell population of particular interest for biomedical research and regenerative medicine. Various marker combinations enable the isolation of HSCs bu...
Autor:
Teng-Cheong Ha, Boris Fehse, Olga S. Kustikova, Violetta Dziadek, Maike Stahlhut, Gabi Paul, Martijn H. Brugman, Axel Schambach, Michael Rothe, Christopher Baum, Michael A. Morgan
Publikováno v:
Human Gene Therapy. 32:458-472
Retroviral insertional mutagenesis (RIM) is both a relevant risk in gene therapy and a powerful tool for identifying genes that enhance the competitiveness of repopulating hematopoietic stem and pr...
Autor:
Michael Rothe, Michael A. Morgan, Teng-Cheong Ha, Christine S. Falk, Anton Selich, Constantin von Kaisenberg, Axel Schambach
Publikováno v:
Stem Cell Reports
Stem Cell Reports, Vol 13, Iss 2, Pp 262-273 (2019)
Stem Cell Reports, Vol 13, Iss 2, Pp 262-273 (2019)
Summary Mesenchymal stromal cells (MSCs) are used in many clinical applications. However, ex vivo expansion is required to reach clinically relevant cell numbers, which might lead to selection of clones with different characteristics. To follow clona
Autor:
Michael A. Morgan, Axel Schambach, Teng Cheong Ha, Ekaterina Takmakova, Olga S. Kustikova, Maike Stahlhut, Dirk Schaudien, Matthias Eder, Adrian Schwarzer
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-18 (2021)
Scientific Reports
Scientific Reports
Regulation of haematopoietic stem cell fate through conditional gene expression could improve understanding of healthy haematopoietic and leukaemia initiating cell (LIC) biology. We established conditionally immortalised myeloid progenitor cell lines
Autor:
Steven R. Talbot, Ute Modlich, Adrian Schwarzer, Hubert B. Gaspar, Axel Schambach, Rik Gijsbers, Michael Rothe, Anton Selich, Michael A. Morgan, Oliver Dittrich-Breiholz, Violetta Dziadek, Teng Cheong Ha, Juliane W. Schott, Bettina Weigel, Adrian J. Thrasher, Frank J. T. Staal, Antonella L. Bastone
Publikováno v:
Molecular Therapy, 29(12), 3383-3397. CELL PRESS
molecular therapy
Molecular therapy, 29(12):3383-3397
molecular therapy
Molecular therapy, 29(12):3383-3397
Hematopoietic stem cell gene therapy is emerging as a promising therapeutic strategy for many diseases of the blood and immune system. However, several individuals who underwent gene therapy in different trials developed hematological malignancies ca
Autor:
Teng-Cheong, Ha, Maike, Stahlhut, Michael, Rothe, Gabi, Paul, Violetta, Dziadek, Michael, Morgan, Martijn, Brugman, Boris, Fehse, Olga, Kustikova, Axel, Schambach, Christopher, Baum
Publikováno v:
Human gene therapy. 32(9-10)
Retroviral insertional mutagenesis (RIM) is both a relevant risk in gene therapy and a powerful tool for identifying genes that enhance the competitiveness of repopulating hematopoietic stem and progenitor cells (HSPCs). However, focusing only on the